3 research outputs found
Prevalence of idiopathic epilepsy among primary school children in Qena City, Qena governorate, Egypt
Background:Epilepsy among children is a common neurological disorder and may have a major impact on children development though epidemiological studies are limited.
Objectives:To estimate the prevalence of idiopathic epilepsy among primary school children in Qena City, Egypt.
Patients and methods:All primary schools were approached; Students were asked to complete prepared validated questionnaires. 4218 children aged 6-12 years old were screened, out of them 1428 males and 1315 females returned the questionnaires thoroughly fulfilled. Positive cases were subjected to detailed history, neurological examination, electroencephalography and neuroimaging.
Results:21 cases of epilepsy were identified; lifetime prevalence was 7.6/1000, active epilepsy prevalence was 5.8/1000. Epilepsy was more common in males (8.4/1000) than females (6.8/1000). Generalized seizures were significantly higher than focal(76.1%, versus 19%) with prevalence 5.8/1000 and 1.4/1000 respectively. 38% of epileptic children were at 6-8 years. The most common age of onset was 6 to Conclusions: Prevalence of epilepsy among primary school children in Qena city was 7.6/1000, in line with other Egyptian studies and Arab world studies but much higher than most developed countries. Family history of epilepsy, consanguineous marriage of parents and history of febrile seizures were the main risk factors
Recommended from our members
Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience
BackgroundRandomized clinical trials have failed to prove that the safety and efficacy of endovascular treatment for symptomatic intracranial atherosclerotic disease (ICAD) is better than that of medical management. A recent study using a self-expandable stent showed acceptable lower rates of periprocedural complications.ObjectiveTo study the safety and efficacy of a balloon-mounted stent (BMS) in the treatment of symptomatic ICAD.MethodsProspectively maintained databases from 15 neuroendovascular centers between 2010 and 2020 were reviewed. Patients were included if they had severe symptomatic intracranial stenosis in the target artery, medical management had failed, and they underwent intracranial stenting with BMS after 24 hours of the qualifying event. The primary outcome was the occurrence of stroke and mortality within 72 hours after the procedure. Secondary outcomes were the occurrence of stroke, transient ischemic attacks (TIAs), and mortality on long-term follow-up.ResultsA total of 232 patients were eligible for the analysis (mean age 62.8 years, 34.1% female). The intracranial stenotic lesions were located in the anterior circulation in 135 (58.2%) cases. Recurrent stroke was the qualifying event in 165 (71.1%) while recurrent TIA was identified in 67 (28.9%) cases. The median (IQR) time from the qualifying event to stenting was 5 (2–20.75) days. Strokes were reported in 13 (5.6%) patients within 72 hours of the procedure; 9 (3.9%) ischemic and 4 (1.7%) hemorrhagic, and mortality in 2 (0.9%) cases. Among 189 patients with median follow-up time 6 (3–14.5) months, 12 (6.3%) had TIA and 7 (3.7%) had strokes. Three patients (1.6%) died from causes not related to stroke.ConclusionOur study has shown that BMS may be a safe and effective treatment for medically refractory symptomatic ICAD. Additional prospective randomized clinical trials are warranted